• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
CHEN Jiajia, BEI Yuncheng, ZHANG Dongmei, SHEN Pingping. Combination of artemether with etoposide inhibits cell proliferation and invasion in small cell lung cancer cell line H446[J]. Journal of China Pharmaceutical University, 2017, 48(2): 201-207. DOI: 10.11665/j.issn.1000-5048.20170211
Citation: CHEN Jiajia, BEI Yuncheng, ZHANG Dongmei, SHEN Pingping. Combination of artemether with etoposide inhibits cell proliferation and invasion in small cell lung cancer cell line H446[J]. Journal of China Pharmaceutical University, 2017, 48(2): 201-207. DOI: 10.11665/j.issn.1000-5048.20170211
shu

Combination of artemether with etoposide inhibits cell proliferation and invasion in small cell lung cancer cell line H446

More Information
    Graphical Abstract
    • Abstract
  • This study was to investigate the inhibitory effects of artemether in combination with etoposide on the proliferation and invasion ability of human small cell lung cancer cell line H446. H446 cells were treated with different concentrations of artemether or etoposide alone or their combination. The inhibitory effects on proliferation were detected by MTT assay, while cell cycle and apoptosis of H446 cells in each group were analyzed by flow cytometry using PI and Annexin V/PI-staining, respectively. The invasion capability of H446 cells in different groups was tested with matrigel-coated transwell. The results implicated that artemether or etoposide or their combination does inhibit proliferation of H446 cells dose-dependently. Artemether alone had little effect on the apoptosis of H446 cells while its combination with etoposide resulted in significantly apoptosis of H446 cells comparing with other groups(P< 0. 05). Etoposide blocked H446 progression markedly by arresting cell cycle in G2 phase with percentage of cells in G1 phase decreasing significantly while artemether alone or in combination with etoposide had little synergetic effect on cell cycle. Artemether or etoposite alone or their combination could dramatically inhibit the invasion ability of H446 cells.
    • FullText(HTML)
    • References (11)
  • [1]
    Byers LA,Rudin CM.Small cell lung cancer:where do we go from here[J]?Cancer,2015,121(5):664-672.
    [2]
    Asai N,Ohkuni Y,Kaneko N,et al.Relapsed small cell lung cancer:treatment options and latest developments[J].Ther Adv Med Oncol,2014,6(2):69-82.
    [3]
    Chaturvedi D,Goswami A,Saikia PP,et al.Artemisinin and its derivatives:a novel class of anti-malarial and anti-cancer agents[J].Chem Soc Rev,2010,39(2):435-454.
    [4]
    Chen T,Li M,Zhang R,et al.Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy[J].J Cell Mol Med,2009,13(7):1358-1370.
    [5]
    Gong Y,Gallis BM,Goodlett DR,et al.Effects of transferrin conjugates of artemisinin and artemisinin dimer on breast cancer cell lines[J].Anticancer Res,2013,33(1):123-132.
    [6]
    Lai HC,Singh NP,Sasaki T.Development of artemisinin compounds for cancer treatment[J].Invest New Drugs,2013,31(1):230-46.
    [7]
    Lu JJ, Chen SM, Zhang XW, et al. The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells[J].Invest New Drugs,2011,29(6):1276-1283.
    [8]
    Das AK.Anticancer effect of antimalarial artemisinin compounds[J].Ann Med Health Sci Res,2015,5(2):93-102.
    [9]
    Guo T,Li HY,Yin XZ,et al. Mechanism of cyclodextrin inclusion of artemisinins in vacuum[J].J China Pharm Univ(中国药科大学学报),2010,41(6):513-519.
    [10]
    Simos D,Sajjady G,Sergi M,et al.Third-line chemotherapy in small-cell lung cancer:an international analysis[J].Clin Lung Cancer,2014,15(2):110-118.
    [11]
    Ho WE,Peh HY,Chan TK,et al.Artemisinins:pharmacological actions beyond anti-malarial[J].Pharmacol Ther,2014,142(1):126-139.
    • Related Articles

  • Related Articles

    [1]CHEN Xi, JIN Liang. Research progress on sumoylation in type 2 diabetes mellitus[J]. Journal of China Pharmaceutical University, 2025, 56(1): 125-131. DOI: 10.11665/j.issn.1000-5048.2023112002
    [2]JIANG Xiaomei, LIU Chong. Neuroprotective effect of glycyrrhizin on diabetic retinopathy[J]. Journal of China Pharmaceutical University, 2020, 51(6): 711-717. DOI: 10.11665/j.issn.1000-5048.20200610
    [3]MU Jinming, LIU Yue, ZHANG Fangfang, JIN Liang. Relationship between circular RNA and type 2 diabetes and its clinical application[J]. Journal of China Pharmaceutical University, 2020, 51(3): 374-378. DOI: 10.11665/j.issn.1000-5048.20200316
    [4]TAO Yingjun, WU Jie, LIU Chang. Application of proteomics in diabetes and its complications[J]. Journal of China Pharmaceutical University, 2020, 51(3): 368-373. DOI: 10.11665/j.issn.1000-5048.20200315
    [5]YANG Xiaojun, AI Fengfeng, LIN Junbing, TANG Jiangjiang. Chemical constituents extracted from Dictamnus dasycarpus and their α-glucosidase inhibitory activity[J]. Journal of China Pharmaceutical University, 2019, 50(1): 41-45. DOI: 10.11665/j.issn.1000-5048.20190105
    [6]TANG Qian, CHEN Song, GAO Xiangdong. Advances of mechanisms of metabolic memory-based diabetic complications and therapeutic drugs[J]. Journal of China Pharmaceutical University, 2017, 48(5): 622-628. DOI: 10.11665/j.issn.1000-5048.20170519
    [7]HU Mengyue, LIU Can, ZHANG Mian, HU Nan, LIU Li, LIU Xiaodong. Alteration of cytochrome P450s activity under diabetic conditions and its impact on the development of diabetes mellitus[J]. Journal of China Pharmaceutical University, 2014, 45(2): 153-160. DOI: 10.11665/j.issn.1000-5048.20140204
    [8]WANG Xin-ting, ZHANG Mian, GUO Hai-fang, LIU Can, HU Nan, LIU Li, LIU Xiao-dong. Effect and mechanism of atorvastatin on blood glucose of mild diabetic rats[J]. Journal of China Pharmaceutical University, 2012, 43(5): 453-459.
    [9]XU Si-sheng, ZHANG Hui-bin, ZHOU Jin-pei, HUANG Jian-jun. Advances of new antidiabetic drugs[J]. Journal of China Pharmaceutical University, 2011, 42(2): 97-106.
    [10]PREVENTION AND TREATMENT OF ALLOXAN-INDUCED DIABETES IN MICE BY POLYSACCHARIDES FROM SPORE OF TREMELLA FUCIFORMIS BERK[J]. Journal of China Pharmaceutical University, 1988, (4): 303-304.

  • Cited by

    Periodical cited type(2)

    1. 林会平，孙国绍，梁波. 两种7-羟基香豆素衍生物的合成和NMR分析. 广州化学. 2020(01): 31-37 .
    2. 雷志伟，尹荣秀，李露露，郭灿. 香豆素类化合物合成的研究概况. 贵州茶叶. 2019(03): 18-21 .

    Other cited types(2)

Catalog

    Get Citation
    PDF
    XML
    Article views (773) PDF downloads (1421) Cited by(4)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：302641

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return